ERCC1 expression predicts treatment response and survival in advanced uterine cervical cancer patients treated with platinum-based chemotherapy

被引：0
|
作者：
Baek, S. W. [1 ]
Choi, Y. S. [1 ]
Song, I. C. [1 ]
Yun, H. J. [1 ]
Jo, D. Y. [1 ]
Kim, S. Y. [1 ]
Lee, H. J. [1 ]
机构：
[1] Chungnam Natl Univ Hosp, Intenal Med, Daejeon, South Korea
来源：
ANNALS OF ONCOLOGY | 2015年 / 26卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
274P
引用
收藏
页码：81 / 82
页数：2
相关论文
共 50 条
  • [41] Predictive Value of the ERCC1 Expression for Treatment Response and Survival in Advanced Gastric Cancer Patients Receiving Cisplatin-based First-line Chemotherapy
    Yun, Jina
    Kim, Kyoung-Mee
    Kim, Seung Tae
    Kim, Jung-Hoon
    Kim, Jung A.
    Kong, Jee Hyun
    Lee, Soo Hyeon
    Won, Young-Woong
    Sun, Jong-Mu
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Park, Young Suk
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER RESEARCH AND TREATMENT, 2010, 42 (02): : 101 - 106
  • [42] ERCC1 expression levels predict the outcome of platinum-based chemotherapies in advanced bladder cancer: a meta-analysis
    Li, Shan
    Wu, Junrong
    Chen, Yongbin
    Tang, Weizhong
    Peng, Qiliu
    Deng, Yan
    Xie, Li
    Wang, Jian
    Huang, Shan
    Li, Ruolin
    Qin, Xue
    Zhao, Jinmin
    ANTI-CANCER DRUGS, 2014, 25 (01) : 106 - 114
  • [43] ERCC1 and BRCA1 mRNA expression predicts the clinical outcome of non-small cell lung cancer receiving platinum-based chemotherapy
    Feng Xian-jun
    Qin Xiu-guang
    Zang Li
    Feng Hui
    Wang Wan-ling
    Liu Dong
    Li Ping-fa
    PAKISTAN JOURNAL OF MEDICAL SCIENCES, 2014, 30 (03) : 488 - 492
  • [44] Use of ERCC1 expression levels in circulating tumor cells to predict to response to platinum-based chemotherapy in patients with non-small cell lung cancer
    Hoffmann, A. C.
    Gauler, T.
    Parr, A.
    Eberhardt, W. E.
    Schuler, M. H.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [45] Study of the Relationship between ERCC1 Polymorphisms and Response to Platinum-based Chemotherapy in Iranian Patients with Colorectal and Gastric Cancers
    Abyarghamsari, Mandiye
    Shirazi, Farshad Hosseini
    Tavakoli-Ardakani, Maria
    Rezvani, Hamid
    Mirzaei, Hamid Reza
    Salamzadeh, Jamshid
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2019, 18 (04): : 2163 - 2171
  • [46] Expression of ERCC1, MSH2 and PARP1 in Non-small Cell Lung Cancer and Prognostic Value in Patients Treated with Platinum-based Chemotherapy
    Xie, Ke-Jie
    He, Hong-Er
    Sun, Ai-Jing
    Liu, Xi-Bo
    Sun, Li-Ping
    Dong, Xue-Jun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (06) : 2591 - 2596
  • [47] The effects of ERCC1 expression levels on the chemosensitivity of gastric cancer cells to platinum agents and survival in gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy
    Liu, Yong-Ping
    Ling, Yang
    Qi, Qiu-Feng
    Zhang, Ya-Ping
    Zhang, Chang-Song
    Zhu, Chang-Tai
    Wang, Mei-Hua
    Pan, Yao-Dong
    ONCOLOGY LETTERS, 2013, 5 (03) : 935 - 942
  • [48] Immunohistochemical expression of BCRP and ERCC1 in biopsy specimen predicts survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy
    Ota, Shuji
    Ishii, Genichiro
    Goto, Koichi
    Kubota, Kaoru
    Kim, Young Hak
    Kojika, Masakazu
    Murata, Yukinori
    Yamazaki, Manabu
    Nishiwaki, Yutaka
    Eguchi, Kenji
    Ochiai, Atsushi
    LUNG CANCER, 2009, 64 (01) : 98 - 104
  • [49] Redox protein expression predicts progression-free and overall survival in ovarian cancer patients treated with platinum-based chemotherapy
    Woolston, Caroline M.
    Deen, Suha
    Al-Attar, Ahmad
    Shehata, Mohamed
    Chan, Stephen Y.
    Martin, Stewart G.
    FREE RADICAL BIOLOGY AND MEDICINE, 2010, 49 (08) : 1263 - 1272
  • [50] ERCC1 and ERCC2 Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer
    Barba, Andres
    Lopez-Vilaro, Laura
    Ferre, Malena
    Majem, Margarita
    Martinez-Recio, Sergio
    Bell, Olga
    Arranz, Maria J.
    Salazar, Juliana
    Sullivan, Ivana
    PHARMACEUTICS, 2024, 16 (09)
12345